Maven Bio
by Maven Bio
Sourced BioPharma research on drugs, clinical trials, companies, mechanisms, financings, and deals
Maven Bio is an evidence-backed BioPharma research connector for consultants, investors, and in-house life sciences teams. It gives Microsoft Copilot direct access to Maven Bio's linked knowledge graph of drugs, companies, clinical trials, mechanisms, targets, and indications, along with the FDA filings, SEC filings, clinical papers, press releases, and conference abstracts that support them.
Ask in plain language and get sourced, structured answers instead of summaries. Resolve messy drug and company names and aliases to canonical entities; map a competitive landscape for an indication by phase, company, or mechanism; rank drug development activity by company, target, or indication; and pull public-company financials, cross-company financing rounds, and licensing and M&A deal activity for comparison. Find and read primary-source documents by Maven ID, clinical-trial NCT ID, or public URL, and extract citable claims. Track recent FDA actions, trial readouts, and press for a company, drug, or saved monitor.
It also includes 16 research skills, such as asset profiles, competitive pipelines, deal activity, and market sizing, that guide Copilot through multi-step research with sources. Every tool is read-only and scoped to your own account and organization. Tools return structured, source-linked results designed for decision-grade work, and pair naturally: discover a landscape, then confirm high-value claims against primary documents.
An active Maven Bio account is required. Users sign in through a Maven Bio sign-in pop-up (OAuth 2.0). No API keys or passwords are shared with Copilot.
Sign up: https://mavenbio.com/signup
Get started: https://mavenbio.com/integrations/mcp
Help: https://mavenbio.com/support
Contact us: https://mavenbio.com/contact or help@mavenbio.io
App capabilities
- Can send data over the Internet
- This app can access personal information on the active message, such as phone numbers, postal addresses, or URLs. Other items in your mailbox cannot be read or modified. Review the developer's privacy policy for more detail on how personal information is managed and processed.